Biomarker analysis for prostate cancer diagnosis using LC-MS and CE-MS

Bioanalysis

Volumn 3, Issue 18, 2011, Pages 2129-2142

  Gamagedara, Sanjeewa ^a   Ma, Yinfa ^a  

^a MISSOURI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; 8 HYDROXYDEOXYGUANOSINE; ANDROSTANOLONE; ARACHIDONIC ACID; BIOLOGICAL MARKER; CREATININE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ATMOSPHERIC PRESSURE CHEMICAL IONIZATION; ATMOSPHERIC PRESSURE PHOTOIONIZATION; CANCER DIAGNOSIS; CANCER STAGING; CAPILLARY ELECTROPHORESIS; CREATININE URINE LEVEL; ELECTROSPRAY; ELECTROSPRAY MASS SPECTROMETRY; GLEASON SCORE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IONIZATION; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROSTATE CANCER; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRACENTRIFUGATION; URINALYSIS;

BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; DEOXYADENOSINES; DEOXYGUANOSINE; ELECTROPHORESIS, CAPILLARY; HUMANS; MALE; PROSTAGLANDINS; PROSTATIC NEOPLASMS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 80053293384     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.11.203     Document Type: Review

References (39)

1. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to prostate cancer risk in China. Cancer Epidemiol. Biomarkers Prev. 12(7), 665-668 (2003). (Pubitemid 36899850)
2. Jacobs EJ, Rodriguez C, Mondul AM et al. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J. Natl Cancer Inst. 97(13), 975-980 (2005). (Pubitemid 41430563)
3. Urisman A, Molinaro RJ, Fischer N et al. Identification of a novel gretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2(3), e25 (2006).
4. van der Cruijsen-Koeter IW, Vis AN, Roobol MJ et al. Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam. J. Urol. 174(1), 121-125 (2005). (Pubitemid 40825690)
5. Thompson IM, Pauler DK, Goodman PJ et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter. N. Engl. J. Med. 350 (22). 2239-2246 (2004).
6. Hayes DF, Bast RC, Desch CE et al. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J. Natl Cancer Inst. 88(20), 1456-1466 (1996). (Pubitemid 26340047)
7. van den Bemd GJ, Krijgsveld J, Luider TM, van Rijswijk AL, Demmers JA, Jenster G. Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice. Mol. Cell. Proteomics 5(10), 1830-1839 (2006). (Pubitemid 44688192)
8. Teichert F, Verschoyle RD, Greaves P et al. Determination of 8-oxo-2′-deoxyguanosine and creatinine in murine and human urine by liquid chromatography-tandem mass spectrometry: application to chemoprevention studies. Rapid Commun. Mass Spectrom. 23(2), 258-266 (2009).
9. Higashi T, Takayama N, Kyutoku M, Shimada K, Koh E, Namiki M. Liquid chromatography-mass spectrometric assay of androstenediol in prostatic tissue: influence of androgen deprivation therapy on its level. Steroids 71(11-12), 1007-1013 (2006). (Pubitemid 44573303)
10. Nithipatikom K, Laabs ND, Isbell MA, Campbell WB. Liquid chromatographic- mass spectrometric determination of cyclooxygenase metabolites of arachidonic acid in cultured cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 785(1), 135-145 (2003). (Pubitemid 36078445)
11. Tang S, Bhatia B, Maldonado CJ et al. Evidence that arachidonate 15-lipoxygenase 2 is a negative cell cycle regulator in normal prostate epithelial cells. J. Biol. Chem. 277(18), 16189-16201 (2002). (Pubitemid 34967907)
12. Stokvis E, Rosing H, Lopez-Lazaro L et al. Quantitative analysis of the novel depsipeptide anticancer drug Kahalalide F in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray ionization tandem mass spectrometry. J. Mass Spectrom. 37(9), 992-1000 (2002).
13. Chen L, Giorgianni F, Beranova- Giorgianni S. Characterization of the phosphoproteome in LNCaP prostate cancer cells by in-gel isoelectric focusing and tandem mass spectrometry. J. Proteome Res. 9(1), 174-178 (2010).
14. Cantone JL, Xu-Lin A, Toyn JH, Drexler DM. Application of quantitative LC-MS surrogate peptide methodology in the analysis of the amyloid b peptide (Ab) biosynthetic intermediate protein APP-bCTF. J. Neurosci. Methods 180(2), 255-260 (2009).
15. Berna MJ, Zhen Y, Watson DE, Hale JE, Ackermann BL. Strategic use of immunoprecipitation and LC-MS/MS for trace-level protein quantification: myosin light chain 1, a biomarker of cardiac necrosis. Anal. Chem. 79(11), 4199-4205 (2007). (Pubitemid 46903173)
16. Gamagedara S, Gibbons S, Ma Y. Investigation of urinary pteridine levels as potential biomarkers for non-invasive diagnosis of cancer. Clin. Chim. Acta 412(1-2), 120-128 (2011).
17. Jiang Y, Cheng X, Wang C, Ma Y. Quantitative determination of sarcosine and related compounds in urinary samples by liquid chromatography with tandem mass spectrometry. Anal. Chem. 82 (21), 9022-9027 (2010).
18. Sardana G, Marshall J, Diamandis EP. Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin. Chem. 53(3), 429-437 (2007). (Pubitemid 46447939)
19. Backstrom M, Thomsson KA, Karlsson H, Hansson GC. Sensitive liquid chromatography-electrospray mass spectrometry allows for the analysis of the O-glycosylation of immunoprecipitated proteins from cells or tissues: application to MUC1 glycosylation in cancer. J. Proteome Res. 8(2), 538-545 (2009).
20. Fortin T, Salvador A, Charrier JP et al. Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/ milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests. Mol. Cell. Proteomics 8(5), 1006-1015 (2009).
21. Tian Q, Kent KD, Bomser JA, Schwartz SJ. Characterization of limonin glucoside metabolites from human prostate cell culture medium using high-performance liquid chromatography-electrospray ionization mass spectrometry and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 18(24), 3099-3104 (2004). (Pubitemid 39664913)
22. Higashi T, Yamauchi A, Shimada K, Koh E, Mizokami A, Namiki M. Determination of prostatic androgens in 10 mg of tissue using liquid chromatography-tandem mass spectrometry with charged derivatization. Anal. Bioanal. Chem. 382(4), 1035-1043 (2005).
23. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231), 910-914 (2009).
24. Gamagedara S, Kaczmarek A, Cheng X, Ma Y. Investigation of urinary sarcosine and related biomarkers in prostate and other urological cancers using LC-MS/MS. Presented at: The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy. Atlanta, GA, USA, 14 March 2011.
25. Jentzmik F, Stephan C, Miller K et al. Sarcosine in urine after digital rectal examination fails as a marker in prostate cancer detection and identification of aggressive tumours. Eur. Urol. 58(1), 12-18 (2010).
26. Lih FB, Titus MA, Mohler JL, Tomer KB. Atmospheric pressure photoionization tandem mass spectrometry of androgens in prostate cancer. Anal. Chem. 82(14), 6000-6007 (2010).
27. Hakala KS, Laitinen L, Kaukonen AM, Hirvonen J, Kostiainen R, Kotiaho T. Development of LC-MS/MS methods for cocktail dosed Caco-2 samples using atmospheric pressure photoionization and electrospray ionization. Anal. Chem. 75(21), 5969-5977 (2003). (Pubitemid 37356480)
28. Yamamoto A, Kakutani N, Yamamoto K, Kamiura T, Miyakoda H. Steroid hormone profiles of urban and tidal rivers using LC-MS/MS equipped with electrospray ionization and atmospheric pressure photoionization sources. Environ. Sci. Technol. 40(13), 4132-4137 (2006). (Pubitemid 44161665)
29. Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. d5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells. Proc. Natl Acad. Sci. USA 95(19), 11083-11088 (1998). (Pubitemid 28450085)
30. Mischak H, Coon JJ, Novak J, Weissinger EM, Schanstra JP, Dominiczak AF. Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom. Rev. 28(5), 703-724 (2009).
31. Theodorescu D, Fliser D, Wittke S et al. Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine. Electrophoresis 26(14), 2797-2808 (2005). (Pubitemid 41078989)
32. Theodorescu D, Schiffer E, Bauer HW et al. Discovery and validation of urinary biomarkers for prostate cancer. Proteomics Clin. Appl. 2(4), 556-570 (2008). (Pubitemid 351566263)
33. Coon JJ, Zurbig P, Dakna M et al. CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin. Appl. 2(7-8), 964 (2008).
34. Donohue MJ, Satterfield MB, Dalluge JJ, Welch MJ, Girard JE, Bunk DM. Capillary electrophoresis for the investigation of prostate-specific antigen heterogeneity. Anal. Biochem. 339(2), 318-327 (2005). (Pubitemid 40395290)
35. Wittke S, Schiffer E, Bauer HW. Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer. Urologe A 46(7), 733-739 (2007). (Pubitemid 47047746)
36. Kremmer T, Szollosi E, Boldizsar M et al. Liquid chromatographic and mass spectrometric analysis of human serum acid a-1-glycoprotein. Biomed. Chromatogr. 18(5), 323-329 (2004). (Pubitemid 39106929)
37. Mitamura K, Nagaoka Y, Shimada K et al. Simultaneous determination of androstenediol 3-sulfate and dehydroepiandrosterone sulfate in human serum using isotope diluted liquid chromatography-electrospray ionization-mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 796(1), 121-130 (2003). (Pubitemid 38352716)
38. Cho HJ, Kim JD, Lee WY, Chung BC, Choi MH. Quantitative metabolic profiling of 21 endogenous corticosteroids in urine by liquid chromatography-triple quadrupole-mass spectrometry. Anal. Chim. Acta 632(1), 101-108 (2009).
39. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Liquid chromatography/ tandem mass spectrometric method for the quantification of eight proteolytic fragments of ITIH4 with biomarker potential in human plasma and serum. Rapid Commun. Mass Spectrom. 22(18), 2915-2928 (2008).